Lawrence K E, Lethwick D M, Rhodes A P, Jackson R, Heuer C, Pomroy W E, West D M, Waghorn T S, Moffat J R
Institute of Veterinary Animal and Biomedical Sciences, Massey University, Private Bag 11 222, Palmerston North, New Zealand.
N Z Vet J. 2007 Oct;55(5):228-34. doi: 10.1080/00480169.2007.36773.
To report current farmer opinions and farming practices relating to control of gastrointestinal nematodes and anthelmintic resistance on sheep farms in New Zealand.
An interview-based cross-sectional study of grazing management and anthelmintic usage was conducted by veterinarians on 80 randomly selected sheep farms in New Zealand.
Useable data were returned by 74/80 (92%) farmers who participated in the study. However, despite contacting 400 farmers the target sample size of 100 farms was not reached. The results indicated that only 31% of farms had previously tested for drench resistance, that effective quarantine-drenching of imported stock was not always carried out, and that farmers were more likely to integrate cattle than ewes into their grazing management of lambs. Furthermore, the number of drenches given to lambs had changed little in 25 years. The use of faecal egg counting by farmers has increased.
Dependence on anthelmintics continues to be high on sheep farms in New Zealand. Whilst the number of drench treatments has changed little, there is more widespread use of persistent or long-acting treatments. Farmers need to be encouraged to monitor the resistance status of nematode populations on their farms and use this information to develop strategies aimed at maintaining susceptible alleles within the parasite populations and conserving the efficacy of existing drug families.
报告新西兰养羊场目前农民对胃肠道线虫控制及驱虫抗性的看法和养殖实践。
兽医对新西兰80个随机选取的养羊场进行了一项基于访谈的放牧管理和驱虫药使用情况的横断面研究。
参与研究的80位农民中有74位(92%)返回了可用数据。然而,尽管联系了400位农民,但仍未达到100个农场的目标样本量。结果表明,只有31%的农场之前检测过驱虫药抗性,对进口牲畜的有效隔离驱虫并不总是能做到,而且农民在羔羊放牧管理中更倾向于将牛而非母羊纳入其中。此外,25年来给羔羊的驱虫次数变化不大。农民对粪便虫卵计数的使用有所增加。
新西兰养羊场对驱虫药的依赖程度仍然很高。虽然驱虫处理的次数变化不大,但长效或持久型处理的使用更为广泛。需要鼓励农民监测其农场中线虫种群的抗性状况,并利用这些信息制定策略,以维持寄生虫种群中的敏感等位基因,并保持现有药物类别的疗效。